SYDNEY, Australia & SAN DIEGO--(BUSINESS WIRE)--Novotech, the largest Australian-owned contract research organization (CRO) with offices on the US east and west coasts, is now in rapid expansion mode as the CRO sector fundamentals continue to strengthen with growth of more than 15% per year. Following the company’s successful expansion to the US, Novotech has attracted two leading biotech venture firms BioPacificVentures and Co-Investor Capital Partners as investors in the company and as backers of its overseas expansion plans.
